NCT04900623: An ongoing trial by Jonathan Schoenfeld, MD, MPH
This trial is ongoing. It must report results 5 years, 5 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04900623 |
|---|---|
| Title | Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 2, 2021 |
| Completion date | June 1, 2030 |
| Required reporting date | June 1, 2031, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |